0 likes | 10 Views
Key challenges impacting the success rate for therapy development are lack of information on the virus such as biological, genetic information, duration of immunity granted in recovered patients, among others, which is vital to develop a safe & effective treatment option.
E N D
On March 11, 2020, the World Health Organization declared the outbreak of COVID-19, caused by the novel coronavirus SARS-CoV-2, a global pandemic. Since then, the world has witnessed a relentless battle against this formidable adversary. As of May 15, 2020, the virus had infected nearly 4,347,935 people and claimed the lives of 297,241 individuals worldwide. The COVID-19 pandemic has had profound effects, transcending healthcare and reverberating across economies and societies. Healthcare systems globally have been stretched to their limits in managing the COVID-19 patient population. Concurrently, dedicated researchers and scientists have raced against time to develop diagnostic tools and therapeutic solutions. However, the economic impacts of the pandemic have been felt across various sectors. Worldwide, GDPs have declined, unemployment rates have surged, and inflation rates have risen. The United States, for instance, witnessed over 3.8 million layoffs by the end of April 2020, with roughly 30 million people filing for jobless aid. In the United Kingdom, approximately 7.5 million individuals were covered under the government's furlough scheme. As the world grappled with this unprecedented challenge, several companies emerged as key players in the COVID-19 Diagnostics and Therapy Market. Here are the top 10 companies making significant strides in the battle against COVID- 19: https://meticulousblog.org/top-10-companies-in-covid-19-diagnostics-and-therapy- market 1. Roche Holding AG • • A global biotechnology firm specializing in in-vitro diagnostics. Provides medicines for various disease areas, including oncology, immunology, infectious diseases, and more. Operates with 97,735 employees, 23 manufacturing sites, and 29 R&D sites globally (as of 2019). • 2. Thermo Fisher Scientific, Inc. • • Develops, manufactures, and sells scientific instrumentation, reagents, and consumables. Supplies a wide range of diagnostic test kits, reagents, and associated products. 3. AbbVie Corporation • Focuses on developing innovative advanced therapies for complex conditions in areas such as immunology, oncology, virology, and neuroscience. Operates in over 75 countries, treating over 30 million patients with more than 32 conditions (as of 2019). • 4. Johnson & Johnson • Operates in three business segments: medical devices, pharmaceuticals, and consumer packaged goods. Extensive global presence with research facilities worldwide. • 5. Moderna, Inc. • • Specializes in drug discovery and development using messenger RNA (mRNA) technology. Collaborates with various organizations, including AstraZeneca, Merck, and the Bill & Melinda Gates Foundation. 6. AstraZeneca Plc • Focuses on research, development, production, and marketing of products across eight therapeutic areas.
• Committed to addressing disorders in areas such as oncology, cardiovascular, and respiratory health. 7. Sorrento Therapeutics, Inc. • Engaged in the development of new treatments for cancer, inflammation, and autoimmune diseases. 8. Athersys, Inc. • Concentrates on the development of regenerative medicines, including MultiStem, a clinical stage allogeneic stem cell therapy. 9. Celularity, Inc. • Developing therapies to treat autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. 10. Takeda Pharmaceuticals Company LTD. - A global biopharmaceutical firm with a diverse research and development focus spanning oncology, digestive system diseases, rare diseases, and neurology. These companies have played pivotal roles in the global response to the COVID-19 pandemic, from diagnostic advancements to therapeutic breakthroughs. For more comprehensive information on these companies, their recent financial performance, key products, strategies, and partnerships, please refer to Meticulous Research®'s report, "Opportunity Analysis and Industry Forecast (2020-2025) on the COVID-19 Diagnostics and Therapy Market." This report provides in-depth insights into the global market size, market share analysis, revenue figures, and coverage of key industry trends and developments. For media inquiries or further information, please contact: https://meticulousblog.org/top- 10-companies-in-covid-19-diagnostics-and-therapy-market